Culligan v. Secretary of Health and Human Services

CourtUnited States Court of Federal Claims
DecidedApril 22, 2016
Docket14-318
StatusPublished

This text of Culligan v. Secretary of Health and Human Services (Culligan v. Secretary of Health and Human Services) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Culligan v. Secretary of Health and Human Services, (uscfc 2016).

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 14-318V Filed: March 31, 2016

* * * * * * * * * * * * * * * * * EMILY CULLIGAN, * TO BE PUBLISHED * Petitioner, * Special Master Hamilton-Fieldman v. * * SECRETARY OF HEALTH * Attorney Hourly Rate; Attorney Hours; AND HUMAN SERVICES, * Expert Hourly Rate; Expert Hours; Interim * Attorneys’ Fees and Costs. Respondent. * * * * * * * * * * * * * * * * * *

Mark Krueger, Krueger & Hernandez, SC, Baraboo, WI, for Petitioner. Lara Englund, United States Department of Justice, Washington, DC, for Respondent.

DECISION AWARDING INTERIM ATTORNEYS’ FEES AND COSTS 1

On November 4, 2015, Emily Culligan (“Petitioner”) filed a motion for an interim award of attorneys’ fees and costs pursuant to 42 U.S.C. § 300aa-15(e). 2 After careful consideration, the undersigned grants the request in part.

1 The undersigned intends to post this Decision Awarding Interim Attorneys’ Fees and Costs on the United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, codified as amended at 44 U.S.C. § 3501 note (2012). As provided by Vaccine Rule 18(b), each party has 14 days within which to file a motion for redaction “of any information furnished by that party (1) that is trade secret or commercial or financial information and is privileged or confidential, or (2) that are medical files and similar files the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). 2 The applicable statutory provisions defining the Vaccine Program (“the Program”) are found at 42 U.S.C. § 300aa-10 et seq. (2012). Hereinafter, for ease of citation, all § references will be to 42 U.S.C. (2012).

1 I. PROCEDURAL BACKGROUND

On April 18, 2014, Petitioner filed a Petition alleging that Human Papillomavirus vaccinations (“Gardasil” or “HPV vaccines”) on March 31, 2010, June 1, 2010, and October 4, 2010 caused her to suffer from premature ovarian failure (“POF”). Petition (“Pet”) at 1-2. Petitioner was, and continues to be, represented by Mark Krueger of the Krueger and Hernandez law firm. Pet. at 2. The case was initially assigned to Special Master Christian Moran. Notice of Assignment, April 18, 2014.

Petitioner filed seven medical record exhibits between May 20 and July 21, 2014; in the interim, the case, along with several others filed by petitioners who had alleged similar injuries caused by Gardasil, was reassigned to the undersigned. See Notice of Reassignment, filed June 17, 2014. Petitioner filed a statement of completion on July 30, 2014.

On August 14, 2014, Respondent filed a Rule 4(c) Report and Motion to Dismiss (“Respondent’s Report”) in which she contended that Petitioner was not entitled to a Program award. Respondent argued that the first symptom of Petitioner’s POF was oligomenorrhea, 3 which Petitioner experienced in “late 2010;” accordingly, Petitioner’s claim was untimely under 42 U.S.C. § 300aa-16(a)(2) (requiring that petitions be filed prior to “the expiration of 36 months after the date of the occurrence of the first symptom or manifestation of onset … of injury”) [hereinafter “the statute of limitations”]. Respondent’s Report at 4. Respondent also argued that, even if Petitioner’s claim was not time-barred, Petitioner had failed to prove causation under Althen v. Secretary of Health and Human Services, 418 F.3d 1274, 1278 (Fed. Cir. 2005). Respondent’s Report at 4-5.

At a status conference held on September 23, 2014, the undersigned discussed with the parties the necessity of establishing an onset date in the instant case – and in the other cases in which Mr. Krueger had alleged that petitioners’ POF had been caused by Gardasil vaccinations – in order to assess the timeliness of those cases under the statute of limitations. See Order, filed Sept. 25, 2014, at 1. The undersigned directed Petitioner to begin the process of identifying all of the POF petitioners so that an assessment of onset could take place in all of those cases. Id.

On October 1, 2014, Petitioner filed a status report in which she identified eight POF cases to be included in the undersigned’s assessment of onset. 4 See Petitioner’s Status Report,

3 Oligomenorrhea is defined as “menstrual flow happening less often than normal, defined as at intervals of 35 days to 6 months; called also infrequent menstruation.” Dorland’s Illustrated Medical Dictionary (“Dorland’s”), 1318 (32nd ed. 2012) (emphasis in orginal). 4 The cases identified were Alexander, 14-868V; Culligan, 14-318V; Fishkis, 14-527V; Lee, 14-258V; Lydia McSherry, 14-154V; Meghan McSherry, 14-153V; Stone, 13-289V; and Tilley, 14-818V. 2 filed Oct. 1, 2014, at 1. Petitioner subsequently named the instant case – Culligan, 14-318V – as the onset “test case.” See Petitioner’s Status Report, filed Nov. 5, 2014, at 1.

A third status conference was held on November 20, 2014, during which the parties agreed that, “in all pending [POF] cases … an expert hearing [would] be held to address the question of what constitutes ‘the first symptom or manifestation of [POI5/POF] onset recognized as such by the medical profession at large.’” Order, filed Nov. 24, 2014, at 1 (citing Cloer v. Sec’y of Health & Human Servs., 654 F.3d 1322, 1340 (Fed. Cir. 2011)). The undersigned explained that an onset determination would be made on the basis of the evidence presented at the Culligan onset hearing; similar hearings would not be conducted in the other POF cases, all of which would trail Culligan for purposes of an onset determination. See Order, filed Nov. 24, 2014, at 1. The undersigned also added four additional POF cases 6 to the list of cases set to trail Culligan. Id.

The parties and the undersigned proceeded to identify questions for the experts, to be researched and answered before the hearing, regarding the nature and timing of onset in the POF cases. See, e.g., Respondent’s Status Report, filed Oct. 28, 2014, at 1; Order, filed Nov. 24, 2014, at 2; Petitioner’s Status Report, filed Dec. 29, 2014, at 1; Order, filed Jan. 30, 2015, at 1; Order, filed Feb. 18, 2015, at 1. The parties and their experts ultimately agreed that, except in Culligan, in which the entire medical record would be considered by the experts, the experts would “offer opinions regarding the onset issues in the trailing cases by considering the facts of those cases as hypotheticals.” Joint Status Report, filed Jan. 20, 2015, at 1. To facilitate this process, Petitioner filed summaries of the facts of all twelve POF cases. See Petitioner’s Exhibit (“Pet. Ex.”) 9 (summarizing the facts of the twelve POF cases). 7 Except in Culligan, the experts were to rely on the factual summaries, in lieu of the medical records themselves, to articulate their opinions regarding onset. See Joint Status Report, filed Jan. 20, 2015, at 1.

5 “POI” refers to primary ovarian insufficiency, which is defined as “a condition in which a woman is running low on her egg supply or is completely out of eggs before the age of 40 …. POI associated with lack of menstrual cycles has been more commonly called Premature Ovarian Failure (POF).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Culligan v. Secretary of Health and Human Services, Counsel Stack Legal Research, https://law.counselstack.com/opinion/culligan-v-secretary-of-health-and-human-services-uscfc-2016.